Combination of agomelatine and bupropion for treatment‐resistant depression: results from a chart review study including a matched control group

Publisher： John Wiley & Sons Inc

E-ISSN： 2162-3279|5|4|n/a-n/a

ISSN： 2162-3279

Source： Brain And Behavior, Vol.5, Iss.4, 2015-04, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of Vagus Nerve Stimulation for Treatment-Resistant Depression

By Marangell L.B.   Rush A.J.   George M.S.   Georges D.   Sackeim H.A.  

Epilepsy & Behavior, Vol. 2, Iss. 3, 2001-06 ,pp. : 6-10

Elsevier

Access to resources Recommend Favorite

Valdoxan (agomelatine) in the Treatment of Depression in Cerebrovascular Diseases (results of the Russian Resonance multicenter naturalistic study)

By Pizova N.  

Neuroscience and Behavioral Physiology, Vol. 44, Iss. 3, 2014-03 ,pp. : 315-319

Springer Publishing Company

Access to resources Recommend Favorite

Aripiprazole Augmentation in Treatment-Resistant Depression

By BARBEE JAMES   CONRAD ERICH   J. JAMHOUR NOWAL  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 16, Iss. 4, 2004-10 ,pp. : 189-194

Informa Healthcare

Access to resources Recommend Favorite

Pragmatic randomized controlled trial of long‐term psychoanalytic psychotherapy for treatment‐resistant depression: the Tavistock Adult Depression Study (TADS)

By  

World Psychiatry, Vol. 1723-8617, Iss. 3, 2015-10 ,pp. : 312-321

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pragmatic randomized controlled trial of long‐term psychoanalytic psychotherapy for treatment‐resistant depression: the Tavistock Adult Depression Study (TADS)

By  

World Psychiatry, Vol. 14, Iss. 3, 2015-10 ,pp. : 312-321

John Wiley & Sons Inc

Access to resources Recommend Favorite